Winston J. Churchill - 07 Jun 2021 Form 4 Insider Report for Baudax Bio, Inc.

Role
Director
Signature
/s/ Richard S. Casten, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Jun 2021
Net transactions value
+$19,509
Form type
4
Filing time
08 Jun 2021, 16:14:10 UTC
Previous filing
03 Jun 2021
Next filing
31 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BXRX Common Stock Purchase $11,661 +15,000 +11% $0.7774 147,185 07 Jun 2021 Direct
transaction BXRX Common Stock Purchase $7,848 +10,000 +6.8% $0.7848 157,185 07 Jun 2021 Direct
holding BXRX Common Stock 6,500 07 Jun 2021 By Family Partnership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.